67 related articles for article (PubMed ID: 38534214)
1. CD99 at the crossroads of physiology and pathology.
Pasello M; Manara MC; Scotlandi K
J Cell Commun Signal; 2018 Mar; 12(1):55-68. PubMed ID: 29305692
[TBL] [Abstract][Full Text] [Related]
2. Cell Adhesion Molecule CD99 in Cancer Immunotherapy.
Yu F; Liu G; Zhang H; Wang X; Wu Z; Xu Q; Wu Y; Chen D
Curr Mol Med; 2023; 23(10):1028-1036. PubMed ID: 36214301
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD99 Antibody Therapy Triggers Macrophage-Dependent Ewing Cell Death In Vitro and Myeloid Cell Recruitment In Vivo.
O'Neill AF; Nguyen EM; Maldonado ED; Chang MR; Sun J; Zhu Q; Marasco WA
Antibodies (Basel); 2024 Mar; 13(1):. PubMed ID: 38534214
[TBL] [Abstract][Full Text] [Related]
4. Targeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody.
O'Neill AF; Dearling JL; Wang Y; Tupper T; Sun Y; Aster JC; Calicchio ML; Perez-Atayde AR; Packard AB; Kung AL
Clin Cancer Res; 2014 Feb; 20(3):678-87. PubMed ID: 24218512
[TBL] [Abstract][Full Text] [Related]
5. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
Franzetti GA; Laud-Duval K; Bellanger D; Stern MH; Sastre-Garau X; Delattre O
Oncogene; 2013 Aug; 32(33):3915-21. PubMed ID: 22986530
[TBL] [Abstract][Full Text] [Related]
6. CD99 engagement: an effective therapeutic strategy for Ewing tumors.
Scotlandi K; Baldini N; Cerisano V; Manara MC; Benini S; Serra M; Lollini PL; Nanni P; Nicoletti G; Bernard G; Bernard A; Picci P
Cancer Res; 2000 Sep; 60(18):5134-42. PubMed ID: 11016640
[TBL] [Abstract][Full Text] [Related]
7. Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity.
Balestra T; Manara MC; Laginestra MA; Pasello M; De Feo A; Bassi C; Guerzoni C; Landuzzi L; Lollini PL; Donati DM; Negrini M; Magnani M; Scotlandi K
Mol Cancer Ther; 2022 Jan; 21(1):58-69. PubMed ID: 34667115
[TBL] [Abstract][Full Text] [Related]
8. Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages.
Manara MC; Manferdini C; Cristalli C; Carrabotta M; Santi S; De Feo A; Caldoni G; Pasello M; Landuzzi L; Lollini PL; Salamanna F; Dominici S; Fiori V; Magnani M; Lisignoli G; Scotlandi K
Cancer Immunol Res; 2024 Feb; 12(2):247-260. PubMed ID: 38051221
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the PI3K/AKT/mTOR signaling promotes an M1 macrophage switch by repressing the ATF3-CXCL8 axis in Ewing sarcoma.
Palombo R; Passacantilli I; Terracciano F; Capone A; Matteocci A; Tournier S; Alberdi A; Chiurchiù V; Volpe E; Paronetto MP
Cancer Lett; 2023 Feb; 555():216042. PubMed ID: 36565919
[TBL] [Abstract][Full Text] [Related]
10. Prognostic profiling of the immune cell microenvironment in Ewing´s Sarcoma Family of Tumors.
Stahl D; Gentles AJ; Thiele R; Gütgemann I
Oncoimmunology; 2019; 8(12):e1674113. PubMed ID: 31741777
[TBL] [Abstract][Full Text] [Related]
11. Preclinical Evaluation of Vemurafenib as Therapy for BRAF
Gouravan S; Meza-Zepeda LA; Myklebost O; Stratford EW; Munthe E
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29570692
[TBL] [Abstract][Full Text] [Related]
12. Cancer immunotherapy targeting the CD47/SIRPα axis.
Weiskopf K
Eur J Cancer; 2017 May; 76():100-109. PubMed ID: 28286286
[TBL] [Abstract][Full Text] [Related]
13. CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling.
Manara MC; Terracciano M; Mancarella C; Sciandra M; Guerzoni C; Pasello M; Grilli A; Zini N; Picci P; Colombo MP; Morrione A; Scotlandi K
Oncotarget; 2016 Nov; 7(48):79925-79942. PubMed ID: 27835596
[TBL] [Abstract][Full Text] [Related]
14. CD99 as surface anchor for human islet endocrine cell purification.
Martens GA; De Punt V; Stangé G
J Tissue Eng Regen Med; 2018 Jan; 12(1):e171-e176. PubMed ID: 27687889
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
